Literature DB >> 213513

Effects of secretagogues and theophylline on canine gastric mucosal cyclic nucleotides.

R A Levine, E H Schwartzel, S Bachman, J N Talev.   

Abstract

cAMP and cGMP concentrations were measured in gastric mucosa in 18 anesthetized mongrel dogs receiving infusions of histamine (16 microgram/kg/hr), pentagastrin (6 microgram/kg/hr), bethanechol (10 microgram/kg/min), and theophylline (150 mg bolus, then 10 mg/min). The possible synergistic effect of continuous theophylline infusion with the secretagogues was studied in 15 other acute experiments. Antral and fundic mucosa were biopsied and measured by radioimmunoassay for cyclic nucleotides. All the secretagogues did not significantly change antral or fundic mucosal cyclic nucleotide concentrations compared to basal levels. In contrast, phosphodiesterase inhibition by theophylline significantly increased cAMP 11-fold and cGMP threefold in both antrum and fundus. Concomitant infusion of each secretagogue with theophylline did not potentiate the mucosal nucleotide response compared to theophylline alone. In a separate series of 19 experiments in three anesthetized dogs with vagally denervated fundic (Heidenhain) pouches, all the secretagogues which were infused in the same doses as in the acute biopsy studies produced maximal acid secretory responses. Theophylline, on the other hand, failed to stimulate acid secretion in five Heidenhain pouch experiments. These studies fail to implicate cyclic nucleotides as mediators of stimulated canine gastric acid secretion.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 213513

Source DB:  PubMed          Journal:  J Lab Clin Med        ISSN: 0022-2143


  2 in total

1.  Studies on the source of cyclic AMP in canine gastric juice.

Authors:  E H Schwartzel; R A Levine
Journal:  Dig Dis Sci       Date:  1979-04       Impact factor: 3.199

2.  Cyclic GMP and acid production in isolated gastric cells of the rat.

Authors:  H K Heim; H J Ruoff
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1985-08       Impact factor: 3.000

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.